Device Trial Radar · NCT07888738
Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary Procedures
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Nov 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Terumo Europe N.V.Public (4543.T)
- Sponsor type
- Industry
- First posted
- Oct 22, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study has been organised to learn more about the safety and use of the TR Band Distal device in patients who have had a heart procedure through a blood vessel in the wrist near the base of the thumb (called distal radial access). The study will look at how well the device helps stop bleeding after the procedure, while still allowing blood to flow normally through the blood vessel in the wrist.
Conditions
- Hemostasis
- Distal Radial Artery Access (dTRA)
Interventions
TR Band DistalDevice
Coronary procedure via distal radial access using the TR Band Distal
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Achieving Successful Hemostasis Within 24 HoursTime frame: Within 24 hours following the index procedure
Locations
7 sites in 4 countries. Site status is shown where the registry gives one.
Krankenhaus Eisenstadt
Eisenstadt, Austria
Cliniques universitaires Saint-Luc
Brussels, Belgium
CHU Charleroi
Charleroi, Belgium
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.